Jarno Robin

Jarno Robin is an experienced professional in the biopharmaceutical field, currently serving as the Pharma Business Development Director at SANI Membranes since March 2023. Previously, Jarno held various leadership roles at LEO Pharma, including Director/Head of Global MSAT Biologics Drug Substances and Head of MSAT API Process, where significant contributions included managing global strategies, increasing production yield, and overseeing major capital investments. Jarno's expertise also encompasses senior positions at Sanofi as Director/Head of Upstream Biopharmaceutical Process Development, and at Novo Nordisk A/S as Principal Scientist and Technology Project Manager. Academic credentials include a Ph.D. from DTU and an M.Sc. from INSA Toulouse, complemented by a strong foundation in biochemical principles and industrial applications.